CVRX INC (CVRX) — insider trading
Health Care · NASDAQ
CVRX INC (CVRX) has 24 reported SEC Form 4 insider transactions in our data, including 1 open-market purchase and 3 open-market sales among the most recent 24 (latest 2026-08-13).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-13 | Binkowski Brent | Officer (CHIEF OPERATING OFFICER) | Open-market purchase | 26,223 | $2.91 | $76.4K | Form 4 |
| 2026-08-12 | Binkowski Brent | Officer (CHIEF OPERATING OFFICER) | Open-market sale | 1,309 | $2.55 | $3.3K | Form 4 |
| 2026-06-01 | DALE MICHAEL D | Director | Grant / award / vesting (derivative) | 36,252 | — | $0 | Form 4 |
| 2026-06-01 | DALE MICHAEL D | Director | Grant / award / vesting | 29,005 | — | $0 | Form 4 |
| 2026-06-01 | SHADAN MARTHA | Director | Grant / award / vesting (derivative) | 11,182 | — | $0 | Form 4 |
| 2026-06-01 | SHADAN MARTHA | Director | Grant / award / vesting | 8,720 | — | $0 | Form 4 |
| 2026-06-01 | Ballinger Kevin J. | Director | Grant / award / vesting (derivative) | 11,182 | — | $0 | Form 4 |
| 2026-06-01 | Ballinger Kevin J. | Director | Grant / award / vesting | 8,720 | — | $0 | Form 4 |
| 2026-06-01 | Hill, Mitch C. | Director | Grant / award / vesting (derivative) | 11,182 | — | $0 | Form 4 |
| 2026-06-01 | Hill, Mitch C. | Director | Grant / award / vesting | 8,720 | — | $0 | Form 4 |
| 2026-06-01 | SLATTERY JOSEPH P | Director | Grant / award / vesting (derivative) | 11,182 | — | $0 | Form 4 |
| 2026-06-01 | SLATTERY JOSEPH P | Director | Grant / award / vesting | 8,720 | — | $0 | Form 4 |
| 2026-06-01 | Jain Mudit K. | Director | Grant / award / vesting (derivative) | 11,182 | — | $0 | Form 4 |
| 2026-06-01 | Jain Mudit K. | Director | Grant / award / vesting | 8,720 | — | $0 | Form 4 |
| 2026-06-01 | Nielsen Kirk G. | Director | Grant / award / vesting (derivative) | 11,182 | — | $0 | Form 4 |
| 2026-06-01 | Nielsen Kirk G. | Director | Grant / award / vesting | 8,720 | — | $0 | Form 4 |
| 2026-03-02 | Adamson Philip B. | Officer (Chief Medical Officer) | Open-market sale | 1,262 | $7.90 | $10.0K | Form 4 |
| 2026-03-02 | Morrison Gregory | Officer (CHIEF HUMAN RESOURCES OFFICER) | Grant / award / vesting (derivative) | 154,500 | — | $0 | Form 4 |
| 2026-03-02 | Morrison Gregory | Officer (CHIEF HUMAN RESOURCES OFFICER) | Grant / award / vesting | 34,000 | — | $0 | Form 4 |
| 2026-03-02 | Hykes Kevin | Director, Officer (PRES & CEO) | Open-market sale | 7,763 | $7.90 | $61.3K | Form 4 |
| 2026-02-27 | Adamson Philip B. | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 62,000 | — | $0 | Form 4 |
| 2026-02-27 | Adamson Philip B. | Officer (Chief Medical Officer) | Grant / award / vesting | 41,000 | — | $0 | Form 4 |
| 2026-02-27 | Hykes Kevin | Director, Officer (PRES & CEO) | Grant / award / vesting (derivative) | 238,000 | — | $0 | Form 4 |
| 2026-02-27 | Hykes Kevin | Director, Officer (PRES & CEO) | Grant / award / vesting | 159,000 | — | $0 | Form 4 |
Ask the chat about CVRX's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: CVRX INC (CVRX).
Last updated 2026-08-13 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.